Serial Number
79395221
Owner
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.Filing Date
Dec 27, 2023
RENBIOLOGICS Trademark
Serial Number: 79395221
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
No.12, Baoshen South Street,
Entity Type: 03
Legal Representation
Correspondence Address
Biocytogen Pharmaceuticals (Beijing) Co. Ltd.
,
Trademark Details
Filing Date
December 27, 2023
Registration Date
Not Registered
Goods & Services
Medicines for human purposes; biological preparations for medical purposes; preparations of microorganisms for medical or veterinary use; biological tissue cultures for medical purposes; colostral antibodies for medical purposes; vaccines; living cells for medical purposes; biochemical medicines; pharmaceutical preparations; pharmaceutical substances; medical preparations for treating diseases and disorders related to the immune system; pharmaceutical preparations for the prevention and treatment of cancer; diagnostic preparations for medical purposes; dietetic substances adapted for medical use; medicines for veterinary purposes.
Protein [raw material]; radioactive elements for scientific purposes; preparations of trace elements for plants; biochemical preparations for scientific purposes; biological preparations, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; biological tissue cultures other than for medical or veterinary purpose; bacteriological preparations other than for medical and veterinary use; preparations of microorganisms, other than for medical and veterinary use; proteins for the food industry.
Technological research; biochemical research and analysis; drug development; pharmaceutical product evaluation; clinical trials; research and development services in the field of antibodies; biological research; research in the field of gene editing technology; research in the field of cell engineering technology; culturing of cells for scientific research purposes; development of pharmaceutical preparations and pharmaceuticals; biomedical research.